If Channel Inhibition - Ivabradine for the Treatment of Heart Failure

The novel first-in-class If channel antagonist, Ivabradine, is effective in improving clinical outcomes and functional capacity, in patients with HF, as well as demonstrating useful anti-anginal and protective anti-ischaemic effects. It can help improve heart rate control and can be usefully co-admi...

Full description

Bibliographic Details
Main Authors: Giuseppe MC Rosano, Cristiana Vitale
Format: Article
Published: Barcaray International 2019-01-01
Series:International Cardiovascular Forum Journal
Online Access:https://icfjournal.org/index.php/icfj/article/view/599/pdf